ESR1 and breast carcinoma: In summary, estrogen activity modulates the expression of many immunomodulators and modifiers of the extracellular matrix in multiple target cell types that are present in the TME of ER+ breast cancers, consistent with widespread estrogen receptor expression (Section 4, Figure 1).